tiprankstipranks
Precision Optics Corporation (POCI)
NASDAQ:POCI
US Market

Precision Optics Corporation (POCI) Price & Analysis

16 Followers

POCI Stock Chart & Stats

$4.21
-$0.09(-1.91%)
At close: 4:00 PM EST
$4.21
-$0.09(-1.91%)

Bulls Say, Bears Say

Bulls Say
Revenue Growth & Program RampsSustained top-line growth and a record quarter show durable demand and successful commercialization of key programs. Higher volume provides a path to absorb fixed costs, supports scale advantages, and underpins management’s timeline for margin recovery if yields and throughput remain on track.
Operational Yield ImprovementsMaterial yield and throughput gains indicate improving manufacturing control and product maturity. Higher yields cut scrap and unit costs, enabling structurally higher gross margins for that product line and making future revenue more profitable and repeatable as production scales.
Manageable Leverage / Equity CushionRelatively low leverage and a tangible equity base provide financing flexibility during a turnaround. This balance-sheet position reduces near-term insolvency risk, supports negotiation of additional facilities, and gives the company room to invest in operational fixes without immediate balance-sheet distress.
Bears Say
Severe Margin CompressionSharp, persistent margin deterioration materially weakens cash generation and the economics of core products. Unless cost, yield, or price dynamics improve sustainably, low margins will constrain reinvestment and make the business structurally loss-making despite revenue growth.
Negative Cash Flow & Low LiquidityOngoing cash burn and a very small cash balance create persistent refinancing risk. Structural reliance on external funding can force dilutive capital raises or restrictive debt terms, limiting strategic options and slowing necessary investments to secure sustainable margins.
Negative EBITDA Guidance & Profitability RiskManagement’s downward EBITDA revision signals that operational fixes are not yet sufficient to restore profitability. Recurring negative EBITDA reduces internal cash generation, increases dependence on external capital, and implies material execution risk to reach sustained positive operating earnings.

Precision Optics Corporation News

POCI FAQ

What was Precision Optics Corporation’s price range in the past 12 months?
Precision Optics Corporation lowest stock price was $3.55 and its highest was $6.04 in the past 12 months.
    What is Precision Optics Corporation’s market cap?
    Precision Optics Corporation’s market cap is $32.97M.
      When is Precision Optics Corporation’s upcoming earnings report date?
      Precision Optics Corporation’s upcoming earnings report date is May 14, 2026 which is in 38 days.
        How were Precision Optics Corporation’s earnings last quarter?
        Precision Optics Corporation released its earnings results on Feb 17, 2026. The company reported -$0.231 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.231.
          Is Precision Optics Corporation overvalued?
          According to Wall Street analysts Precision Optics Corporation’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Precision Optics Corporation pay dividends?
            Precision Optics Corporation does not currently pay dividends.
            What is Precision Optics Corporation’s EPS estimate?
            Precision Optics Corporation’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Precision Optics Corporation have?
            Precision Optics Corporation has 7,720,229 shares outstanding.
              What happened to Precision Optics Corporation’s price movement after its last earnings report?
              Precision Optics Corporation reported an EPS of -$0.231 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.644%.
                Which hedge fund is a major shareholder of Precision Optics Corporation?
                Currently, no hedge funds are holding shares in POCI
                What is the TipRanks Smart Score and how is it calculated?
                Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                  Precision Optics Corporation Stock Smart Score

                  Company Description

                  Precision Optics Corporation

                  Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.

                  Precision Optics Corporation (POCI) Earnings & Revenues

                  POCI Earnings Call

                  Q2 2026
                  0:00 / 0:00
                  Earnings Call Sentiment|Neutral
                  The call presents a mixed but constructive picture: strong top-line momentum and multiple operational improvements (record revenue, program ramps, yield improvements, higher backlog and bookings) are offset by severe near-term margin pressure, negative adjusted EBITDA, low cash, and a one-quarter delay in margin recovery. Management expects margin and EBITDA improvement in H2 and has raised full-year revenue guidance, but financing and execution risks remain.View all POCI earnings summaries
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Retractable Technologies
                  Milestone Scientific
                  Femasys
                  NexGel Inc

                  Ownership Overview

                  4.61%12.45%6.15%74.07%
                  6.15% Other Institutional Investors
                  74.07% Public Companies and
                  Individual Investors

                  Options Prices

                  Currently, No data available
                  ---
                  Popular Stocks